We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$5.38M
Cap. Flow
-$5.42M
Cap. Flow %
-4.55%
Top 10 Hldgs %
36.72%
Holding
80
New
8
Increased
27
Reduced
7
Closed
11
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$1.8M
2
WBA icon
Walgreens Boots Alliance
WBA
+$1.67M
3
BIDU icon
Baidu
BIDU
+$1.6M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.53M
5
BABA icon
Alibaba
BABA
+$1.47M

Sector Composition

Rank Sector Weight
1 Healthcare 42.71%
2 Industrials 9.53%
3 Technology 8.54%
4 Materials 8.18%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NEUE icon
76
DELISTED
NeueHealth
NEUE
– –
-18,000
Closed -$137K –
USAP icon
77
DELISTED
Universal Stainless & Alloy
USAP
– –
-34,000
Closed -$683K –
TAST icon
78
DELISTED
Carrols Restaurant Group, Inc.
TAST
– –
-350,000
Closed -$2.76M –
IMGN icon
79
DELISTED
Immunogen Inc
IMGN
– –
-500,000
Closed -$14.8M –
SFE
80
DELISTED
Safeguard Scientifics, Inc.
SFE
– –
-671,671
Closed -$527K –

Similar funds

CM Management's Q1 2024 Portfolio in Review

As of Q1 2024, CM Management held 80 positions worth $119M, down 4.3% from $124M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management withdrew a net $5.42M in Q1 2024, closing 11 positions and reducing 7 holdings. Its most notable exit was Immunogen Inc, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.

Against the trend, CM Management opened a new position in Incyte worth $1.71M.

  • CM Management's largest Q1 2024 buy was Incyte: 30,000 shares worth $1.71M.
  • CM Management added most to Walgreens Boots Alliance in Q1 2024, an estimated $1.67M increase.
  • CM Management's biggest Q1 2024 reduction was BGC Group, cutting an estimated $1.85M.
  • CM Management fully exited Immunogen Inc in Q1 2024, selling an estimated $14.8M.
  • CM Management's ten largest holdings make up 37% of its $119M portfolio in Q1 2024.
  • CM Management opened 8 new positions and closed 11 in Q1 2024.
  • CM Management's portfolio value fell 4.3% quarter-over-quarter to $119M.

Based on CM Management's 13F filing for Q1 2024, filed 14 May 2024.